Biocept's Patented Platform Identifies Clinically HER2-Negative Patients With HER2-Positive Circulating Tumor Cells
December 17, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Dec. 17, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor cells (CTCs) and circulating...
Biocept Expands Worldwide Microchannel Patent Protection to South Korea
December 15, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
Biocept Appoints Experienced Physician as Medical Director
December 03, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
Biocept Reports Third Quarter 2014 Financial Results
November 13, 2014 16:05 ET
|
Biocept, Inc.
SAN DIEGO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
Biocept Launches Lung Cancer Offering
November 12, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor...
Biocept, Inc. Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results
November 06, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (cfDNA) and...
Biocept and Rosetta Genomics Collaborate to Evaluate microRNAs From Circulating Tumor Cells
October 13, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO and PRINCETON, N.J. and REHOVOT, Israel, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of...
Biocept Expands Collaboration With MD Anderson Cancer Center
October 07, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating...
Biocept to Present at the 13th Annual BIO Investor Forum
September 30, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating Tumor Cells
September 18, 2014 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...